Laura Aitken

832 total citations
24 papers, 671 citations indexed

About

Laura Aitken is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Laura Aitken has authored 24 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Laura Aitken's work include Alzheimer's disease research and treatments (13 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Hormonal Regulation and Hypertension (5 papers). Laura Aitken is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Hormonal Regulation and Hypertension (5 papers). Laura Aitken collaborates with scholars based in United Kingdom, Czechia and United States. Laura Aitken's co-authors include Frank J. Gunn‐Moore, Bernard P. Schimmer, K L Parker, Douglas Rice, A R Mouw, Ondřej Benek, Kamil Kuča, Kamil Musílek, Eva Borger and Stuart J. Conway and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and International Journal of Molecular Sciences.

In The Last Decade

Laura Aitken

24 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Aitken United Kingdom 16 298 209 207 176 118 24 671
Shiro Takekawa Japan 15 383 1.3× 143 0.7× 97 0.5× 83 0.5× 42 0.4× 28 818
Jun‐ichi Eiki Japan 17 791 2.7× 423 2.0× 135 0.7× 227 1.3× 22 0.2× 28 1.3k
Alicia R. Hovland United States 11 287 1.0× 66 0.3× 378 1.8× 94 0.5× 96 0.8× 16 719
Carolyn J. Johnson United States 9 327 1.1× 199 1.0× 49 0.2× 264 1.5× 60 0.5× 11 830
Samuele Scurati Italy 9 187 0.6× 82 0.4× 63 0.3× 79 0.4× 34 0.3× 11 506
Samer O. Abdul‐Hay United States 14 238 0.8× 45 0.2× 31 0.1× 260 1.5× 91 0.8× 18 535
Jae‐Wan Huh South Korea 17 384 1.3× 49 0.2× 39 0.2× 132 0.8× 49 0.4× 32 666
Hebe M. Guardiola‐Diaz United States 7 340 1.1× 80 0.4× 57 0.3× 110 0.6× 62 0.5× 9 656
Jacek Mokrosiński Denmark 16 495 1.7× 136 0.7× 100 0.5× 234 1.3× 30 0.3× 25 962
Mary Ann Alejandro United States 14 257 0.9× 68 0.3× 289 1.4× 30 0.2× 29 0.2× 18 636

Countries citing papers authored by Laura Aitken

Since Specialization
Citations

This map shows the geographic impact of Laura Aitken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Aitken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Aitken more than expected).

Fields of papers citing papers by Laura Aitken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Aitken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Aitken. The network helps show where Laura Aitken may publish in the future.

Co-authorship network of co-authors of Laura Aitken

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Aitken. A scholar is included among the top collaborators of Laura Aitken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Aitken. Laura Aitken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Doris, et al.. (2021). Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer’s Disease. Cells. 10(11). 3024–3024. 14 indexed citations
2.
Aitken, Laura, Ondřej Benek, Monika Schmidt, et al.. (2019). Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer’s Disease Treatment. Molecules. 24(15). 2757–2757. 28 indexed citations
3.
Benek, Ondřej, Laura Aitken, Frank J. Gunn‐Moore, et al.. (2018). 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 665–670. 25 indexed citations
4.
Aitken, Laura, Gemma L. Baillie, Andrew Pannifer, et al.. (2017). In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer’s Disease. SLAS DISCOVERY. 22(6). 676–685. 16 indexed citations
5.
Benek, Ondřej, Laura Aitken, Rafael Doležal, et al.. (2017). 6-Benzothiazolyl Ureas, Thioureas and Guanidines are Potent Inhibitors of ABAD/17β-HSD10 and Potential Drugs for Alzheimer"s Disease Treatment: Design, Synthesis and in vitro Evaluation. Medicinal Chemistry. 13(4). 345–358. 23 indexed citations
6.
Aitken, Laura, Ondřej Benek, Patrick Guest, et al.. (2017). [P1–039]: IN VITRO EVALUATION OF BENZOTHIAZOLE‐BASED UREAS AS POTENTIAL ABAD/17β‐HSD10 MODULATORS FOR ALZHEIMER'S DISEASE THERAPEUTICS. Alzheimer s & Dementia. 13(7S_Part_5). 1 indexed citations
7.
Benek, Ondřej, Patrick Guest, Laura Aitken, et al.. (2016). Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment. Bioorganic & Medicinal Chemistry Letters. 26(15). 3675–3678. 28 indexed citations
8.
Aitken, Laura, et al.. (2016). Morphology‐Specific Inhibition of β‐Amyloid Aggregates by 17β‐Hydroxysteroid Dehydrogenase Type 10. ChemBioChem. 17(11). 1029–1037. 13 indexed citations
9.
Guest, Patrick, Ondřej Benek, Ondřej Soukup, et al.. (2016). Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment. Bioorganic & Medicinal Chemistry. 25(3). 1143–1152. 49 indexed citations
10.
Aitken, Laura, Ondřej Benek, Martin Doležal, et al.. (2015). Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs. Current Medicinal Chemistry. 22(6). 730–747. 30 indexed citations
11.
12.
Borger, Eva, et al.. (2013). Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer’s Disease?. Current Alzheimer Research. 10(1). 21–29. 11 indexed citations
13.
Borger, Eva, et al.. (2013). Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?. PubMed. 10(1). 21–9. 25 indexed citations
14.
Borger, Eva, et al.. (2013). Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer's Disease?. Current Alzheimer Research. 10(1). 21–29. 8 indexed citations
15.
Borger, Eva, Laura Aitken, Zoe Allen, et al.. (2011). Mitochondrial β-amyloid in Alzheimer's disease. Biochemical Society Transactions. 39(4). 868–873. 27 indexed citations
16.
Borger, Eva, et al.. (2010). The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease. Biochemical Journal. 426(3). 255–270. 61 indexed citations
17.
Olafson, Robert W., Derek Smith, Laura Aitken, et al.. (2007). Identification, characterization and deduced amino acid sequence of the dominant protease from Kudoa paniformis and K. thyrsites: A unique cytoplasmic cysteine protease. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 149(3). 477–489. 32 indexed citations
18.
Rice, Douglas, Mark S. Kronenberg, A R Mouw, et al.. (1990). Multiple regulatory elements determine adrenocortical expression of steroid 21-hydroxylase.. Journal of Biological Chemistry. 265(14). 8052–8058. 55 indexed citations
19.
Rice, Douglas, M. Sue Kirkman, Laura Aitken, et al.. (1990). Analysis of the promoter region of the gene encoding mouse cholesterol side-chain cleavage enzyme.. Journal of Biological Chemistry. 265(20). 11713–11720. 88 indexed citations
20.
Rice, Douglas, Laura Aitken, G R Vandenbark, et al.. (1989). A cAMP-responsive Element Regulates Expression of the Mouse Steroid 11β-Hydroxylase Gene. Journal of Biological Chemistry. 264(24). 14011–14015. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026